Back to results
US 2015/0148338 A1Published application
Compositions comprising short-acting benzodiazepines
AssigneePaion UK Limited
InventorsJohn Aitken Graham, Alan James Baillie, Kevin Richard Ward, Thomas Peacock
Life of this patent
Estimating the term…
Abstract
A composition is provided with a benzodiazepine and at least one hygroscopic excipient, in particular lactose and/or dextran.
Claims19
1-39. (canceled)
A lyophilized or spray-dried composition comprising at least one benzodiazepine according to formula (I)
- with
- W is H;
- X is CH2;
- n is 1;
- Y is CH2;
- m is 1;
- Z is O;
- p is 0 or 1;
- R1 is CH3, CH2CH3, CH2CH2CH3, CH(CH3)2 or CH2CH(CH3)2;
- R2 is 2-fluorophenyl, 2-chlorophenyl or 2-pyridyl;
- R3 is Cl or Br;
- R4, R5 and R6 form the group-CR8═U—V═ wherein R8 is hydrogen, C1-4 alkyl or C1-3 hydroxyalkyl, U is N or CR9 wherein R9 is H, C1-4 alkyl, C1-3 hydroxyalkyl or C1-4 alkoxy, V is N or CH and p is zero
- or a pharmaceutically acceptable salt thereof, wherein the composition
- comprises at least one pharmaceutically acceptable hygroscopic excipient, wherein the hygroscopic excipient is a carbohydrate selected from the group consisting of disaccharides and dextran.
11 more elements
A stable lyophilized or stable freeze-dried composition comprising at least one benzodiazepine according to formula (I)
- with
- W is H;
- X is CH2;
- n is 1;
- Y is CH2;
- m is 1;
- Z is O;
- p is 0 or 1;
- R1 is CH3, CH2CH3, CH2CH2CH3, CH(CH3)2 or CH2CH(CH3)2;
- R2 is 2-fluorophenyl, 2-chlorophenyl or 2-pyridyl;
- R3 is Cl or Br;
- R4, R5 and R6 form the group-CR8═U—V═ wherein R8 is hydrogen, C1-4 alkyl or C1-3 hydroxyalkyl, U is N or CR9 wherein R9 is H, C1-4 alkyl, C1-3 hydroxyalkyl or C1-4 alkoxy, V is N or CH and p is zero.
- or a pharmaceutically acceptable salt thereof, wherein the composition comprises at least one pharmaceutically acceptable hygroscopic excipient, wherein the hygroscopic excipient is a carbohydrate.
10 more elements
A composition comprising at least one benzodiazepine according to formula (I)
- with
- W is H;
- X is CH2;
- n is 1;
- Y is CH2;
- m is 1;
- Z is O;
- p is 0 or 1;
- R1 is CH3, CH2CH3, CH2CH2CH3, CH(CH3)2 or CH2CH(CH3)2;
- R2 is 2-fluorophenyl, 2-chlorophenyl or 2-pyridyl;
- R3 is Cl or Br;
- R4, R5 and R6 form the group-CR8═U—V═ wherein R8 is hydrogen, C1-4 alkyl or C1-3 hydroxyalkyl, U is N or CR9 wherein R9 is H, C1-4 alkyl, C1-3 hydroxyalkyl or C1-4 alkoxy, V is N or CH and p is zero.
- or a pharmaceutically acceptable salt thereof, wherein the composition comprises at least one pharmaceutically acceptable hygroscopic excipient, wherein the hygroscopic excipient is a carbohydrate.
10 more elements
Dependencies are inferred from the claim text.